Antibodies

21 Nov 2007 Kyto Biopharma Inc. Confirms Definitive Isolation of the Human Vitamin B12 Receptor (TCblR)
20 Nov 2007 Genmab and Glaxosmithkline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
20 Nov 2007 Biogen Idec and Neurimmune Therapeutics Announce Alliance to Develop Treatments for Alzheimer's Disease
19 Nov 2007 Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
19 Nov 2007 Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
16 Nov 2007 CHMP Adopts Negative Opinion on Appeal on European Application For natalizumab for the Treatment of Crohn's Disease
16 Nov 2007 Avastin receives positive opinion in Europe for first-line treatment of patients with advanced kidney cancer
16 Nov 2007 UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
16 Nov 2007 Abbott's HUMIRA(R) Receives Positive Opinion from EMEA for Treatment of Moderate to Severe Plaque Psoriasis
14 Nov 2007 ThromboGenics Begins Preclinical Development of Anti-VPAC Antibody for Thrombocytopenia
14 Nov 2007 New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
13 Nov 2007 New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
12 Nov 2007 Major Phase 3 Trial Shows Zevalin(R) Extends Progression-Free Survival in one of the most common types of Lymphoma
09 Nov 2007 Biogen Idec's Baminercept, the First Lymphotoxin-beta Pathway Inhibitor in Development, Shows Promise in Patients with Rheumatoid Arthritis
09 Nov 2007 Human Genome Sciences Reports Positive Data From Long-Term Treatment With LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
09 Nov 2007 Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia
08 Nov 2007 Dyax Corp. Announces Extension of Antibody Library Collaboration with ImClone Systems
08 Nov 2007 A Second Overseas Phase III Trial Data Demonstrates Efficacy of "Actemra(R)"
08 Nov 2007 Abbott Research Demonstrates Viability of Combining Antibody Functions to Target Two or More Disease-Causing Processes
08 Nov 2007 Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
06 Nov 2007 Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action
06 Nov 2007 Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
05 Nov 2007 Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting
03 Nov 2007 ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis I
02 Nov 2007 Seattle Genetics Initiates SGN-40 Clinical Trial in Combination with Revlimid for Multiple Myeloma

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top